nr |
titel |
type |
1 |
Journal of cardiovascular pharmacology and therapeutics, vol. 16, no. 1 (2011-03)
|
aflevering |
2 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 1 (2014-01)
|
aflevering |
3 |
Journal of cardiovascular pharmacology and therapeutics, vol. 11, no. 1 (2006-03)
|
aflevering |
4 |
Journal of cardiovascular pharmacology and therapeutics, vol. 3, no. 1 (1998)
|
aflevering |
5 |
Journal of cardiovascular pharmacology and therapeutics, vol. 5, no. 1 (2000)
|
aflevering |
6 |
Journal of cardiovascular pharmacology and therapeutics, vol. 8, no. 1 (2003-03)
|
aflevering |
7 |
Journal of cardiovascular pharmacology and therapeutics, vol. 6, no. 1 (2001-03)
|
aflevering |
8 |
Journal of cardiovascular pharmacology and therapeutics, vol. 7, no. 1 (2002-03)
|
aflevering |
9 |
Journal of cardiovascular pharmacology and therapeutics, vol. 13, no. 1 (2008-03)
|
aflevering |
10 |
Journal of cardiovascular pharmacology and therapeutics, vol. 1, no. 1 (1996)
|
aflevering |
11 |
Journal of cardiovascular pharmacology and therapeutics, vol. 9, no. 1 (2004-03)
|
aflevering |
12 |
Journal of cardiovascular pharmacology and therapeutics, vol. 10, no. 1 (2005-01)
|
aflevering |
13 |
Journal of cardiovascular pharmacology and therapeutics, vol. 12, no. 1 (2007-03)
|
aflevering |
14 |
Journal of cardiovascular pharmacology and therapeutics, vol. 2, no. 1 (1997)
|
aflevering |
15 |
Journal of cardiovascular pharmacology and therapeutics, vol. 4, no. 1 (1999)
|
aflevering |
16 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 1 (2012-03)
|
aflevering |
17 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 1 (2017-1)
|
aflevering |
18 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 1 (2015-01)
|
aflevering |
19 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 1 (2018-1)
|
aflevering |
20 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 1 (2012-3)
|
aflevering |
21 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 1 (2013-1)
|
aflevering |
22 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 1 (2016-1)
|
aflevering |
23 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 1 (2013-01)
|
aflevering |
24 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 1 (2019-1)
|
aflevering |
25 |
Journal of cardiovascular pharmacology and therapeutics, vol. 25, no. 1 (2020-1)
|
aflevering |
26 |
Journal of cardiovascular pharmacology and therapeutics, vol. 14, no. 1 (2009-03)
|
aflevering |
27 |
Journal of cardiovascular pharmacology and therapeutics, vol. 15, no. 1 (2010-03)
|
aflevering |
28 |
Journal of cardiovascular pharmacology and therapeutics, vol. 9, no. 1_suppl (2004-3)
|
aflevering |
29 |
Journal of cardiovascular pharmacology and therapeutics, vol. 8, no. 1_suppl (2003-3)
|
aflevering |
30 |
Journal of cardiovascular pharmacology and therapeutics, vol. 7, no. 1_suppl (2002-3)
|
aflevering |
31 |
Journal of cardiovascular pharmacology and therapeutics, vol. 15, no. 2 (2010-06)
|
aflevering |
32 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 2 (2014-03)
|
aflevering |
33 |
Journal of cardiovascular pharmacology and therapeutics, vol. 11, no. 2 (2006-06)
|
aflevering |
34 |
Journal of cardiovascular pharmacology and therapeutics, vol. 8, no. 2 (2003-06)
|
aflevering |
35 |
Journal of cardiovascular pharmacology and therapeutics, vol. 13, no. 2 (2008-06)
|
aflevering |
36 |
Journal of cardiovascular pharmacology and therapeutics, vol. 4, no. 2 (1999)
|
aflevering |
37 |
Journal of cardiovascular pharmacology and therapeutics, vol. 7, no. 2 (2002-06)
|
aflevering |
38 |
Journal of cardiovascular pharmacology and therapeutics, vol. 6, no. 2 (2001-06)
|
aflevering |
39 |
Journal of cardiovascular pharmacology and therapeutics, vol. 9, no. 2 (2004-04)
|
aflevering |
40 |
Journal of cardiovascular pharmacology and therapeutics, vol. 5, no. 2 (2000)
|
aflevering |
41 |
Journal of cardiovascular pharmacology and therapeutics, vol. 12, no. 2 (2007-06)
|
aflevering |
42 |
Journal of cardiovascular pharmacology and therapeutics, vol. 2, no. 2 (1997)
|
aflevering |
43 |
Journal of cardiovascular pharmacology and therapeutics, vol. 3, no. 2 (1998)
|
aflevering |
44 |
Journal of cardiovascular pharmacology and therapeutics, vol. 10, no. 2 (2005-04)
|
aflevering |
45 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 2 (2012-06)
|
aflevering |
46 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 2 (2016-3)
|
aflevering |
47 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 2 (2018-3)
|
aflevering |
48 |
Journal of cardiovascular pharmacology and therapeutics, vol. 16, no. 2 (2011)
|
aflevering |
49 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 2 (2017-3)
|
aflevering |
50 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 2 (2013-03)
|
aflevering |
51 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 2 (2015-03)
|
aflevering |
52 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 2 (2019-3)
|
aflevering |
53 |
Journal of cardiovascular pharmacology and therapeutics, vol. 14, no. 2 (2009-06)
|
aflevering |
54 |
Journal of cardiovascular pharmacology and therapeutics, vol. 15, no. 3 (2010-09)
|
aflevering |
55 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 3 (2013-05)
|
aflevering |
56 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 3 (2014-05)
|
aflevering |
57 |
Journal of cardiovascular pharmacology and therapeutics, vol. 9, no. 3 (2004-07)
|
aflevering |
58 |
Journal of cardiovascular pharmacology and therapeutics, vol. 12, no. 3 (2007-09)
|
aflevering |
59 |
Journal of cardiovascular pharmacology and therapeutics, vol. 13, no. 3 (2008-09)
|
aflevering |
60 |
Journal of cardiovascular pharmacology and therapeutics, vol. 3, no. 3 (1998)
|
aflevering |
61 |
Journal of cardiovascular pharmacology and therapeutics, vol. 7, no. 3 (2002-09)
|
aflevering |
62 |
Journal of cardiovascular pharmacology and therapeutics, vol. 8, no. 3 (2003-09)
|
aflevering |
63 |
Journal of cardiovascular pharmacology and therapeutics, vol. 4, no. 3 (1999)
|
aflevering |
64 |
Journal of cardiovascular pharmacology and therapeutics, vol. 5, no. 3 (2000)
|
aflevering |
65 |
Journal of cardiovascular pharmacology and therapeutics, vol. 6, no. 3 (2001-09)
|
aflevering |
66 |
Journal of cardiovascular pharmacology and therapeutics, vol. 11, no. 3 (2006-09)
|
aflevering |
67 |
Journal of cardiovascular pharmacology and therapeutics, vol. 10, no. 3 (2005-07)
|
aflevering |
68 |
Journal of cardiovascular pharmacology and therapeutics, vol. 2, no. 3 (1997)
|
aflevering |
69 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 3 (2017-5)
|
aflevering |
70 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 3 (2018-5)
|
aflevering |
71 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 3 (2012-9)
|
aflevering |
72 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 3 (2015-05)
|
aflevering |
73 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 3 (2016-5)
|
aflevering |
74 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 3 (2012-09)
|
aflevering |
75 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 3 (2019-5)
|
aflevering |
76 |
Journal of cardiovascular pharmacology and therapeutics, vol. 14, no. 3 (2009-09)
|
aflevering |
77 |
Journal of cardiovascular pharmacology and therapeutics, vol. 16, no. 3-4 (2011-09-12)
|
aflevering |
78 |
Journal of cardiovascular pharmacology and therapeutics, vol. 16, no. 3-4 (2011-9)
|
aflevering |
79 |
Journal of cardiovascular pharmacology and therapeutics, vol. 15, no. 4 (2010-12)
|
aflevering |
80 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 4 (2014-07)
|
aflevering |
81 |
Journal of cardiovascular pharmacology and therapeutics, vol. 2, no. 4 (1997)
|
aflevering |
82 |
Journal of cardiovascular pharmacology and therapeutics, vol. 5, no. 4 (2000)
|
aflevering |
83 |
Journal of cardiovascular pharmacology and therapeutics, vol. 11, no. 4 (2006-12)
|
aflevering |
84 |
Journal of cardiovascular pharmacology and therapeutics, vol. 6, no. 4 (2001-12)
|
aflevering |
85 |
Journal of cardiovascular pharmacology and therapeutics, vol. 8, no. 4 (2003-12)
|
aflevering |
86 |
Journal of cardiovascular pharmacology and therapeutics, vol. 3, no. 4 (1998)
|
aflevering |
87 |
Journal of cardiovascular pharmacology and therapeutics, vol. 4, no. 4 (1999)
|
aflevering |
88 |
Journal of cardiovascular pharmacology and therapeutics, vol. 7, no. 4 (2002-12)
|
aflevering |
89 |
Journal of cardiovascular pharmacology and therapeutics, vol. 10, no. 4 (2005-10)
|
aflevering |
90 |
Journal of cardiovascular pharmacology and therapeutics, vol. 12, no. 4 (2007-12)
|
aflevering |
91 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 4 (2017-7)
|
aflevering |
92 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 4 (2012-12)
|
aflevering |
93 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 4 (2018-7)
|
aflevering |
94 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 4 (2015-07)
|
aflevering |
95 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 4 (2016-7)
|
aflevering |
96 |
Journal of cardiovascular pharmacology and therapeutics, vol. 9, no. 4 (2004)
|
aflevering |
97 |
Journal of cardiovascular pharmacology and therapeutics, vol. 17, no. 4 (2012-12)
|
aflevering |
98 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 4 (2013-07)
|
aflevering |
99 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 4 (2019-7)
|
aflevering |
100 |
Journal of cardiovascular pharmacology and therapeutics, vol. 14, no. 4 (2009-12)
|
aflevering |
101 |
Journal of cardiovascular pharmacology and therapeutics, vol. 15, no. 4_suppl (2010-12)
|
aflevering |
102 |
Journal of cardiovascular pharmacology and therapeutics, vol. 10, no. 4_suppl (2005-10)
|
aflevering |
103 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 5 (2015-9)
|
aflevering |
104 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 5 (2014-09)
|
aflevering |
105 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 5 (2018-9)
|
aflevering |
106 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 5 (2017-9)
|
aflevering |
107 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 5 (2016-9)
|
aflevering |
108 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 5 (2013-09)
|
aflevering |
109 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 5 (2019-9)
|
aflevering |
110 |
Journal of cardiovascular pharmacology and therapeutics, vol. 19, no. 6 (2014-11)
|
aflevering |
111 |
Journal of cardiovascular pharmacology and therapeutics, vol. 22, no. 6 (2017-11)
|
aflevering |
112 |
Journal of cardiovascular pharmacology and therapeutics, vol. 20, no. 6 (2015-11)
|
aflevering |
113 |
Journal of cardiovascular pharmacology and therapeutics, vol. 21, no. 6 (2016-11)
|
aflevering |
114 |
Journal of cardiovascular pharmacology and therapeutics, vol. 18, no. 6 (2013-11)
|
aflevering |
115 |
Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 6 (2018-11)
|
aflevering |
116 |
Journal of cardiovascular pharmacology and therapeutics, vol. 24, no. 6 (2019-11)
|
aflevering |